BRIEF—First oral rapid-acting antidepressant to get Breakthrough desig - The Pharma Letter

BRIEF—First oral rapid-acting antidepressant to get Breakthrough desig  The Pharma LetterThe US Food and Drug Administration has granted Breakthrough Therapy designation for the development of US biotech NeuroRx' NRX-101. The designation ...